L'Oréal beats forecasts, buys growth, and adds Gucci beauty
H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.